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Systems analysis of
host–parasite interactions
Justine Swann,1 Neema Jamshidi,2,3 Nathan E. Lewis4 and Elizabeth A. Winzeler1*
Parasitic diseases caused by protozoan pathogens lead to hundreds of thousands of
deaths per year in addition to substantial suffering and socioeconomic decline for
millions of people worldwide. The lack of effective vaccines coupled with the wide-
spread emergence of drug-resistant parasites necessitates that the research com-
munity take an active role in understanding host–parasite infection biology in
order to develop improved therapeutics. Recent advances in next-generation
sequencing and the rapid development of publicly accessible genomic databases
for many human pathogens have facilitated the application of systems biology to
the study of host–parasite interactions. Over the past decade, these technologies
have led to the discovery of many important biological processes governing para-
sitic disease. The integration and interpretation of high-throughput -omic data will
undoubtedly generate extraordinary insight into host–parasite interactionnetworks
essential to navigate the intricacies of these complex systems. As systems analysis
continues to build the foundation for our understanding of host–parasite biology,
this will provide the framework necessary to drive drug discovery research forward
and accelerate the development of new antiparasitic therapies. © 2015 The Authors.
WIREs Systems Biology and Medicine published by Wiley Periodicals, Inc.
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INTRODUCTION
P rotozoan parasites infect over a half billion peopleworldwide, and continue to play a significant role
in shaping global mortality and morbidity rates despite
decades of research.1 Some important human diseases
caused by these pathogens include malaria, leishmani-
asis, African sleeping sickness, toxoplasmosis, Chagas
disease, and amoebiasis. The lack of government
funding for many of these classically ‘neglected’ patho-
gens, the recent emergence of antiparasitic drug resist-
ance, and the absence of licensed vaccines warrant
global concern. In addition, host–parasite research is
impeded by specific technical and resource limitations.
New cost-effective, high-throughput strategies are
therefore necessary to circumvent these obstacles and
to develop novel therapeutics.
The postgenomic era has generated unparalleled
opportunities for creating and integrating systems biol-
ogy data (i.e., organism- or cellular-scale data pro-
duced through a number of -omic, or system-wide,
technologies). This holistic approach is in direct con-
trast to conventional reductionist methods that
‘reduce’ systems into smaller, more tractable units.
Systems-based methods are particularly useful to study
complex biological relationships that are: (1) open,
with constant information exchange and a net flow
of resources, and (2) stochastic, with spatial, temporal,
and population heterogeneity.2 Host–parasite systems
embody all of these defining characteristics. -Omic
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technologies are also much more efficient and econom-
ical when comparing the cumulative time, labor, and
cost per gene to traditional reductionist strategies. Not
surprisingly, these methods have been critical for
improving our understanding of host–parasite relation-
ships and accelerating antiparasitic drug discovery.3,4 In
this review, we discuss the current state of host–parasite
systems biology research. This includes the various
obstacles faced by parasite researchers, the advance-
ments and feasibility of several genome-wide technolo-
gies, and the key research areas benefiting from such
approaches.We aim to emphasize major advances from
the past few years as well as the specific hypotheses and
gaps emerging from these studies.
UNIQUE CHALLENGES OF THE
HOST–PARASITE INTERFACE
Complex Life Cycles Within
Multiple Hosts
Parasites have evolved elegant strategies to survive and
replicate within their hosts. One strategy includes con-
stantly changing their cellular state in order to progress
through their life cycle, while simultaneously evading
recognition by the host immune system.1 The vast num-
ber of developmental stages, combinedwith distinct tis-
sue tropisms, increases the complexity of host–parasite
interactions (Table 1). In this review, we focus on the
following species owing to their global impact on
humanhealth and influence in the research community:
(1) the Apicomplexans Toxoplasma gondii, which
causes toxoplasmosis, Plasmodium spp., which cause
malaria, and Cryptosporidium spp., which cause the
diarrheal disease cryptosporidosis; (2) the Kinetoplas-
tids Trypanosoma brucei, which causes African sleep-
ing sickness,Trypanosoma cruzi, which causes Chagas
disease, and the Leishmania parasites, which cause
both cutaneous and visceral leishmaniasis; (3) the
DiplomonadGiardia lamblia, which causes the intesti-
nal disease giardiasis; and (4) the Amoebozoa Enta-
moeba histolytica, which causes amoebic dysentery
(Table 1).Many of these parasites, such as the Apicom-
plexans and theKinetoplastids, are vector-borne, intra-
cellular pathogens that complete their life cycle within
multiple hosts. One exception is T. brucei, which car-
ries out its life cycle extracellularly. Others, such as
Cryptosporidium, Entamoeba, and Giardia, can
develop into infectious, resistant cysts that survive out-
side of their hosts and are generally spread via the fecal–
oral route.
Because of the important differences in each
life-cycle stage, researchers must consider these
unique developmental niches as separate systems when
studying host–parasite interactions. This is especially
important for systems-based analysis, as parasites dis-
play periodic stage-dependent gene expression.5
Accordingly, even slight asynchrony within parasite
samples can result in inaccurate gene expression mea-
surements, severely limiting statistical power. This is
particularly challenging when analyzing clinical sam-
ples ex vivo, as parasite populations are rarely homoge-
neous. Therefore, researchers often utilize specialized
techniques in order to synchronize parasites in culture,
isolate specific cellular stages from mixed culture, or
computationally remove stochastic noise.6 While this
experimental isolation of developmental stages will
aid in the understanding of stage-specific host–parasite
interactions, it will also be important for future
systems-based studies to integrate this knowledge into
a multistage model more representative of physiologi-
cal mixed parasite populations.
Challenging In Vitro Culture
While it is certainly possible to utilize systems-based
approaches for in vivo and ex vivo studies, the estab-
lishment of in vitro methods is particularly useful for
many high-throughput applications. The complex
nature of each parasite's life cycle often requires multi-
ple in vitro culture systems in order to study all of the
developmental stages. While some parasite stages are
easily propagated in culture, others are not.7,8 For
example, blood-stage Plasmodium falciparum para-
sites can be maintained almost indefinitely in culture
if supplied with fresh erythrocytes; however, sporo-
zoites are generally freshly isolated from the salivary
glands of infected mosquitos when studying liver-stage
infection. In order to study hypnozoites (the clinically
dormant hepatic stage of Plasmodium vivax and Plas-
modium ovale), researchers rely on technically chal-
lenging, time-intensive assays only available in
locations where the species are accessible.9 The absence
of methods to isolate developmentally synchronized
cysts presents a major hurdle for the study of encysta-
tion and excystation by enteric parasites such as
E. histolytica10 and Cryptosporidium parvum.11 Fur-
thermore, low in vitro infection rates for many proto-
zoan pathogens often lead to insufficient material for
systems-based analysis.
Large Uncharacterized Genomes
Not only are parasite genomes generally larger and
more complex than their prokaryotic counterparts,
but their functional characterization and annotation
is severely limited by lack of both genetic tools and
resources.3 Fully sequenced and annotated genomes
Advanced Review wires.wiley.com/sysbio
382 © 2015 The Authors. WIREs Systems Biology and Medicine published by Wiley Periodicals, Inc. Volume 7, November/December 2015
greatly strengthen many areas of systems-biology
research; this includes determination of coding and
noncoding reading frames, alternative splice variants,
and the assignment of gene functions. Although many
important protozoan parasite genomes have been
sequenced, an overwhelming percentage of genes are
still assigned ‘hypothetical’ functions, as illustrated in
Figure 1. This lack of functional characterization is cor-
related with the relative magnitude of the research
(Figure 1), as well as other factors such as the genetic
TABLE 1 | Protozoan Parasites That Cause Human Disease
Species Disease Host(s) Human Tissue Tropism
Parasite Developmental
Stages
Apicomplexans Toxoplasma
gondii
Toxoplasmosis Domestic cats and
humans
Intestine, muscle, neural
tissue
Oocysts, tachyzoites,
tissue cysts
Plasmodium spp. Malaria Infected female
Anopheles
mosquitos and
humans
Hepatocytes,
erythrocytes, central
nervous system
Sporozoites, liver stages
(trophozoites,
shizonts, merozoites,
hypnozoites in some
species), blood
stages (erythrocyte
ring stages, mature
trophozoites,
shizonts,
merozoites),
gametocytes,
mosquito stages
(zygotes, ookinetes,
oocysts)
Cryptosporidium
spp.
Cryptosporidiosis Humans Epithelial cells of
gastrointestinal or
respiratory tract
Oocysts, sporozoites,
trophozoites,
meronts, merozoites,
gamonts,
microgamonts and
macrogamonts,
zygotes
Kinetoplastids Trypanosoma
brucei
African sleeping
sickness
Tsetse fly and
humans
Bloodstream, lymphatic
system, central nervous
system
Metacyclic
trypomastigotes,
bloodstream
trypomastigotes,
procyclic
trypomastigotes,
epimastigotes
Trypanosoma
cruzi
Chagas disease Triatomine bug and
humans
A variety of cell types near
the site(s) of infection,
bloodstream
Metacyclic
trypomastigotes,
intracellular
amastigotes,
bloodstream
trypomastigotes,
epimastigotes
Leishmania spp. Leishmaniasis Sandflies and
humans
Mononuclear phagocytes
in various tissues
Promastigotes,
amastigotes
Diplomonads Giardia lamblia Giardiasis Humans Small intestine, proximal
small bowel, colon
Cysts, trophozoites
Amoebozoa Entamoeba
histolytica
Amoebic
dysentery
Humans Small intestine, large
intestine, liver, brain,
lungs
Cysts, trophozoites
Information gathered from Centers for Disease Control (CDC), www.cdc.gov.
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intractability of certain species. The24-MbP. falciparum
genome, for example, is extremely AT-rich (80.6%) and
therefore traditional genetic approaches are particularly
challenging.3 Not surprisingly, about 40% of the
genome is still uncharacterized. For other parasites such
as T. gondii and Leishmania major, this number is even
higher, with more than half of annotated genes assigned
‘hypothetical’ functions (Figure 1).
Moreover, the lack of functional characterization
of parasite genomes makes the interpretation of large
datasets difficult. This is especially true when building
system-wide networks based on gene ontology, as dif-
ferentially expressed genes with unknown function are
often excluded, which may lead to an inaccurate repre-
sentation of the system. Because approximately half of
parasite genes fall into this ‘hypothetical’ category, cau-
tion must be taken to express the degree of uncertainty
when clustering datasets into biological processes.
Accordingly, a current focus of parasite biology is to
assign global gene function, and thus genome-wide
technologies rooted in systems biology are essential.
RECENT ADVANCES IN
SYSTEMS-BASED APPROACHES
TO HOST–PARASITE RESEARCH
Application of -Omic Technologies
Systems biology utilizes multiple platforms in order to
survey global cellular processes. These include the
classic -omic technologies, namely transcriptomics,
proteomics, and metabolomics. The recent whole-
genome sequencing of many important human parasite
genomes has led to significant progress in the develop-
ment of these approaches to the study of parasitic dis-
ease. In this section, we will summarize these strategies
and their application to host–parasite interactions.
Transcriptomics
Transcriptomics has been fundamental in shaping our
current understanding of parasite infection biology.
Probe-dependent cDNA microarrays have been a his-
torically useful tool for gene validation and discovery,
as well as determining differential transcript expression
in parasites.12,13 In T. gondii, for example, microarray
analysis led to the identification of developmentally
regulated genes that clustered into distinct processes
such as immune avoidance and sugar metabolism.14
Microarray data have also revealed that
P. falciparum genes in specific pathways are co-
regulated,15 and that many genes that are co-
transcribed share common regulatory elements.16
cDNA microarray chips for a number of protozoan
pathogens are now commercially available, and
recently, the first C. parvum-specific microarray17
was developed and made accessible to the research
community. Microarrays have also provided global
insights into the host response to parasitic
infections.18,19 Cross-hybridization severely limits the
scope of probe-dependent techniques, however, as high
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FIGURE 1 | Percentage of ‘hypothetical’ genes and relative community size for important unicellular human pathogens and their model organisms.
(a) The percentage of ‘hypothetical’ genes for selected prokaryotic and eukaryotic pathogens compared to their relevant model organism, Escherichia coli
and Saccharomyces cerevisiae, respectively. Percentages for each species were calculated from the number of genes including ‘hypothetical,’ ‘unknown,’
or ‘uncharacterized’ in the gene description compared to the total number of pathogen genes from the NCBI database for model organisms and
bacterial pathogens, and from the corresponding EuPathDB databases for protozoan pathogens. (b) The relative community size for model organisms,
and the mean relative community size for the bacterial and protozoan pathogens listed in A, based on the number of results generated from a Pubmed
(http://www.ncbi.nlm.nih.gov/pubmed) search of the species name.
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background reduces the dynamic range of the assay
and parasite and host transcriptomes must be analyzed
separately.20 Probe-independent, tag-based methods
such as serial or cap analysis of gene expression
(SAGE or CAGE, respectively) can provide a more
quantitative picture of the transcriptome, and have
been particularly useful for gene expression analysis
in eukaryotic pathogens, as reviewed elsewhere.21
All of the aforementioned techniques are
restricted by the inability to detect specific mRNA iso-
forms, unannotated noncoding RNAs, and precise
splice junctions. Recent advances in next-generation
sequencing platforms have allowed for deep sequen-
cing of RNA, known as RNA-Seq.22 This approach
provides quantitative full-genome coverage, is
extremely sensitive, and can identify RNA species
and alternative splicing events that are undetectable
by microarray or tag-based analyses. Recent advances
in strand-specific RNA-Seq23–25 have also revealed
widespread transcription of natural antisense tran-
scripts (NATs) in many eukaryotic parasites. So far,
evidence for NATs has been found in species such as
P. falciparum, T. gondii, T. brucei, Leishmania spp.,
andG. lamblia.26 RNA-Seq also enables the simultane-
ous sequencing of both host and parasite
transcriptomes,20 allowing for unprecedented insights
into host–pathogen interactions. In a study by Pittman
et al.,27 in vivo dual RNA-Seq analysis ofT. gondii and
its murine host revealed significant influence of both
the host environment on parasite gene expression as
well as parasite development on host transcription.
Simultaneous sequencing of both human and
P. falciparum RNA isolated from peripheral blood
from 116 malaria patients28 also provided important
insights into host–parasite interactions, including the
identification of host and pathogen genes that correlate
with clinical disease severity. While this paired analysis
provides a much more powerful approach than
single RNA-Seq, the vast majority of -omic datasets
currently survey either the host or the pathogen during
infection. As dual RNA-Seq increases in both resolu-
tion and cost-effectiveness, it will no doubt continue
to provide novel molecular insights into host–parasite
transcriptomics.
Proteomics
Because of innovations in existing technologies and the
development of new methodologies, the field of prote-
omics has made significant progress in surveying the
complex repertoire of proteins that define host–
parasite systems. Mass spectroscopy (MS),29 which
measures the mass-to-charge ratio and abundance of
ions, has been by far the most widely used method
for proteomic analysis. Prior to the advent of genome
sequencing, intact proteins had to be directly analyzed
by MS through technically challenging and low-
throughput ‘top-down’ procedures. The postgenomic
era has significantly benefited from the implementation
of ‘bottom-up’ approaches that instead utilize enzy-
matic or chemical fragmentation of proteins.30 The
protein sequence is then inferred by mapping of the
MS fragmentation spectra to databases built from
annotated genomic information. MS-based
approaches have been fundamental in the assembly
of thewhole-cell proteomes of protozoan parasites dur-
ing multiple life-cycle stages, as reviewed elsewhere.30
Despite the increasing number of proteomic datasets
publicly available for these organisms, there remains
a massive deficit in experimentally validated proteome
coverage (i.e., the percentage of protein-coding genes
TABLE 2 | Experimental Proteome Coverage for Protozoan Parasites
Species Strain
Total
Genes
Protein-Coding
Genes
Proteomic
Expression
Proteome
Coverage (%)
Toxoplasma gondii GT1 8637 8460 4488 53
Plasmodium
falciparum
3D7 5777 5542 4104 74
Cryptosporidium
parvum
Iowa II 3886 3805 1320 35
Trypanosoma brucei TREU927 12,094 11,567 6632 57
Trypanosoma cruzi CL-Brener Esmeraldo-
like
10,597 10,339 3674 36
Leishmania major Friedlin 9378 8400 329 4
Giardia lamblia Assemblage A Isolate
WB
9747 9667 2166 22
Entamoeba histolytica HM-1:IMSS 8333 8306 2443 29
Information gathered from EuPathDB databases, http://eupathdb.org.
WIREs System Biology and Medicine Systems analysis of host–parasite interactions
Volume 7, November/December 2015 © 2015 The Authors. WIREs Systems Biology and Medicine published by Wiley Periodicals, Inc. 385
that have evidence for protein expression) (Table 2).
Moreover, this insufficiency is highly variable among
parasites.While more well-studied protozoan parasites
such as P. falciparum, T. gondii, and T. brucei have
more than 50% proteomic coverage, others, such as
Giardia intestinalis and E. histolytica, have less than
30% coverage, and for L. major, less than 5% of the
predicted proteome is experimentally validated
(Table 2). MS-based methods have also been instru-
mental in profiling the host proteome in response to
parasitic infections. For example, Nelson et al.31 uti-
lized 2D electrophoresis, difference gel electrophoresis,
and MS to profile the host proteomic response to
infection with T. gondii, and analysis of the resulting
dataset suggested extensive global reprogramming
of host metabolic pathways. In a truly integrative
study32 of both parasite and host cell transcriptomic
and proteomic data during the intraerythrocytic devel-
opmental cycle of P. falciparum, 24 human proteins
were identified in significant quantities within the
parasite. Interestingly, these host proteins, like many
parasite proteins found in the same study, displayed
distinct abundance profiles throughout parasite
development.
The current field of parasite proteomics ismoving
toward more sensitive and specific methods. While it is
critical that we continue tomap and annotate both host
and parasite proteomes during infection, it is also
important that we directly measure differential protein
expression in order to better understand host–parasite
biology. This general approach, commonly referred to
as ‘quantitative proteomics,’33 includes relative quanti-
fication methods such as isobaric tagging for relative
and absolute quantification (iTRAQ) and stable iso-
tope labeling by amino acids in cell culture (SILAC),
and label-free methods such as spectral counting.
Quantitative proteomics has been particularly useful
in mapping the phosphoproteomes of many
parasites,34–36 as well as phosphorylated host proteins
in response to parasitic infection.37 These studies have
revealed that reversible protein phosphorylation,
mediated by protein kinases and phosphatases, is an
important regulator of many aspects of host–parasite
biology. In addition to quantitative proteomics, there
has been an increasing interest in mapping the pro-
teomes of subcellular organelles, called ‘organellar pro-
teomics.’38 Organelle isolation prior to proteomic
analysis is commonly achieved by cellular fractionation
or specific labeling and purification methods. This
type of proteomic analysis has enhanced our under-
standing of subcellular protein localization for many
protozoan parasites, such as the nuclear proteome
for P. falciparum39 and the mitochondrial outer mem-
brane proteome for T. brucei.40
Metabolomics
The systems-based application of metabolomics, or the
global survey of small molecules (<1 kDa), has pro-
vided significant insight into the metabolic processes
governing host–parasite infection biology over the last
decade, and has been expertly reviewed elsewhere.41
Because the majority of antiparasitic drugs target
enzymes involved in parasite metabolism, mapping
host–parasite metabolomes will be critical for the
development of novel therapeutics. The study of para-
sitemetabolism has historically relied on the use of low-
throughput radioactive labeling or enzymatic-based
assays. Today, high-throughput MS-based
technologies as well as nuclear magnetic resonance
spectroscopy are the major tools used by researchers
investigating metabolomes.42,43 Pioneering studies
have utilized these technologies to survey the metabo-
lomes for many parasite life-cycle processes, including
Entamoeba cyst formation,44 Leishmania promasti-
gote development,45 Toxoplasma tachyzoite
replication,46 and Plasmodium intraerythrocytic pro-
gression.47 Metabolic labeling coupled with MS is an
effective strategy for measuring metabolic pathway
flux. For example, Ke et al.48 utilized 13C labeling of
P. falciparum genetic knockout lines that have dele-
tions in mitochondrial tricarboxylic acid (TCA) cycle
enzymes to show that mitochondrial metabolism is sur-
prisingly flexible throughout the parasite life cycle.
Additionally, profiling the host metabolome49,50 has
generated valuable information as to how parasites
scavenge host resources and how the host alters its
own metabolism to fight infection. Host metabolomic
studies also have clinical importance, as this information
has been utilized in the identification of diagnostic bio-
markers of protozoan infections.51–53Albeit the applica-
tion of metabolomics to the study of host–parasite
interactions is relatively recent, significant progress has
already been made toward understanding the dynamic
metabolic networks that regulate parasitic infections.
Integrating and Interpreting Large Datasets
Advances in systems-based technologies have required
the development of mathematical methods and compu-
tational tools to integrate and interpret multiple data
types. This reliance will continue to grow as the size
and number of datasets continue to exponentially
increase. The computational approaches employed
in systems biology span various mathematical disci-
plines. Here, we focus on a few examples where the
analysis tools have proven useful. Efforts in data inte-
gration can be broadly grouped into the following
approaches: (1) data organization and network con-
struction, (2) network analyses, and (3) simulation
and modeling.
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DataOrganization andNetworkConstruction
Given the size and number of large -omic screens,
organization of the resulting datasets into databases
is critical to facilitate subsequent integration and anal-
ysis. Publicly available databases for eukaryotic
parasites, as summarized in Table 3, provide the infor-
mation required to populate the 1D annotation of the
organisms, that is, the descriptive content summarizing
each measured biological molecule. Examples of this
include functional annotation or transcript levels for
TABLE 3 | Resources and Databases for Protozoan Parasites
General or Parasite
Species(s) Database Description Web Address
General databases PHI-based: Pathogen-Host
Interactions48
Expertly curated database of
experimentally verified genes from
pathogens
http://www.phi-base.org/
Pathogen Portal Integrative repository linking the
NIAID Bioinformatics Resource
Centers (BRCs) and providing
-omics data for eukaryotic
pathogens, all bacteria, and all
viral families
http://www.pathogenportal.org/
portal/portal/PathPort/Home
ProtozoaDB54 Gene-based protozoan database
with emphasis on distant
similarities (HMM-based) and
phylogeny-based annotations,
including orthology analysis
http://protozoadb.biowebdb.org/
HPIDB: Host–Pathogen Interaction
Database55
Host–pathogen database integrating
experimentally derived protein–
protein interaction data from
various public databases; BLASTP
enabled
http://www.agbase.msstate.edu/
hpi/main.html
PRIDE Archive Proteomics Data
Repository56
European Bioinformatics Institute
repository of mass spectrometry
proteomics data
http://www.ebi.ac.uk/pride/
archive/
EuPathDB (Eukaryotic Pathogen
Database Resources)57
Integrative database of eukaryotic
pathogens housing sequencing
data, microarray data, proteomics
data, metabolic pathways, and
phenotype information
http://eupathdb.org
OMIC tools58 Metadatabase providing a
compendium of over 4400 web-
based tools for the analysis of
genomic, transcriptomic,
proteomic, and metabolomic data
http://omictools.com/
Cryptosporidium
spp.
CryptoDB59 Part of the EuPathDB family of
databases
http://cryptodb.org/cryptodb/
Entamoeba
histolytica
Entamoeba histolytica Assembly and
Annotation60
Assembly and annotation of E.
histolytica with content imported
from AmoebaDB
http://protists.ensembl.org/
Entamoeba_histolytica/Info/
Annotation/
AmoebaDB61 Part of the EuPathDB family of
databases
http://amoebadb.org/amoeba/
Giardia spp. GiardiaDB62 Part of the EuPathDB family of
databases
http://giardiadb.org/giardiadb/
Leishmania spp. Leishmania major—LeischCyc http://biocyc.org/LEISH/organism-
summary?object=LEISH
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an individual gene. As exemplified in the summary plot
of datasets uploaded to EuPathDB60 (Figure 2), there is
generally much greater availability of transcriptomic
data than proteomic data for protozoan pathogens.
In turn, there is much greater availability of proteomic
data thanmetabolomic data. This trend is in part due to
technological advancements in the instrumentation
and the degree of high-throughput profiling that is fea-
sible for each type of measurement. Public metabolomic
databases are also relatively scarce.Metabolights68 is so
far the only cross-species, open-access metabolomic
database available, and there is currently no information
submitted for protozoan parasites. However, as the
value ofmetabolomic data is recognized,41 and the num-
ber of studies profiling host–parasite metabolomics
increases, we anticipate an increase in open-accessmeta-
bolomic databases. In contrast to the 1D annotation of
organisms, the 2D annotation includes defining interac-
tions between biological molecules.69 For example,
protein–protein interactions can be detailed as com-
plexes or signaling pathways, and protein–metabolite
interactions can be described as metabolic reactions
occurring within the organism. The 2D annotation
provides a platform in which different measurements
are integrated and subsequently analyzed in order to
gain meaningful insight into the capabilities and func-
tions of biological organisms.69
TABLE 3 | Continued
General or Parasite
Species(s) Database Description Web Address
Pathway/genome database for
Leishmania major based on the
BioCyc ontology
TriTrypDB63 Part of the EuPathDB family of
databases, resource for
Kinetoplastid species (including
Leishmania spp.)
http://tritrypdb.org/tritrypdb/
Plasmodium spp. PlasmoDB64 Part of the EuPathDB family of
databases
http://plasmodb.org/plasmo/
Full-Malaria Full-length cDNA database of
Plasmodium species with web-
accessible analysis tool
http://fullmal.hgc.jp/index_ajax.
html
Toxoplasma gondii ToxoDB65 Part of the EuPathDB family of
databases
http://toxodb.org/toxo/
Trypanosoma brucei on GeneDB66 Genomic and proteomic database
resources for T. brucei that is part
of the Sanger Institute Pathogen
Program, GeneDB project
http://www.genedb.org/
Homepage/Tbruceibrucei927
Trypanosoma spp. TrypanoCyc67 Pathway/genome database for
T. brucei based on the BioCyc
ontology
http://www.metexplore.fr/
trypanocyc/
TriTrypDB63 Part of the EuPathDB family of
databases, resource for
Kinetoplastid species (including
Trypanosoma spp.)
http://tritrypdb.org/tritrypdb/
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uploaded to EuPathDB for selected Protozoan parasites. The number of
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Once the components of a system are defined,
they need to be merged into a format amenable to
the desired analysis style. The type of network that is
constructed is dependent on the experimental data
available. For example, protein–protein interaction
networks can be constructed from MS spectra gener-
ated after yeast two-hybrid screens or MS spectra gen-
erated after co-immunoprecipitation.16 Metabolic
network connectivity can be determined by individual
metabolites that are linked together via enzymatic (and
transport) reactions. Groups of reactions subsequently
form pathways. Once such information is collected, the
metabolic reactions can be linked together into path-
ways.70 Although advancements in network construc-
tion continue to be made with each new dataset, we
must also be cognizant that we may never completely
characterize all components of an organism nor com-
prehensively detail all interactions. Thus, analysis
methods will need to be tolerant of the incomplete
datasets.71
Network Analyses
Once data are organized and biological networks are
constructed, many different methods can be deployed
to leverage this information for valuable analyses.
The connectivity of biological networks can be studied
using methods from statistics and graph theory to sys-
tematically characterize relationships between different
components (e.g., distance measures and connectivity)
in a network and how the different elements within a
network are organized. For example, 2846 protein–
protein interactions were elucidated for 1312 proteins
in P. falciparum using a high-throughput yeast two-
hybrid assay.71 When the resulting network was ana-
lyzed using gene co-expression data and ontology
information, putative annotation for hypothetical pro-
teins was feasible, and alternative biological functions
were suggested for some annotated genes. Suthram
et al.72 further analyzed this network using a network
alignment approach called PathBLAST,73 an algorithm
that identifies conserved pathways between organisms
by identifying conserved proteins and then testing for
conserved interactions. Through this, the authors
found that few protein interactions were conserved
between Plasmodium and several model organisms,
thus demonstrating that the patterns of protein interac-
tion in Plasmodium are quite distinct.
In Silico Modeling and Simulation
Beyond the analysis of network organization, various
modeling approaches are being employed to simulate
host–pathogen interaction pathways across spatial
and temporal scales. Different types of calculations
can be performed, depending on the modeling
approach that is used. Cell-scale modeling approaches
are proving valuable for integrating and analyzing the
increasingly large volumes of -omic data. One notable
example is constraint-based modeling,26 which uses
metabolic network reconstructions.70 In this approach,
all metabolic reactions in an organism are linked
together and represented in a specificmathematical for-
mat that enables the calculation of network character-
istics as well as simulation of different metabolic
network flux states. As illustrated in Figure 3, every
gene in the network reconstruction includes gene–pro-
tein-reaction associations. These connections describe
how transcripts are related to the proteins they encode,
as well as their corresponding enzymatic reactions.
Network reconstructions thus provide the foundation
for the hierarchical data integration of biological mod-
els. Because the relationships between the components
in these networks are defined by logical relationships, it
is then relatively trivial to integrate multiple types of
different datasets from the host and pathogen and ana-
lyze them simultaneously.
Constraint-based modeling has a growing num-
ber of methodologies74 enabling one to make diverse
predictions including metabolic pathway usage, gene
essentiality, and potential drug targets. Analysis of net-
work reconstructions for L. major has demonstrated
utility in predicting minimal requisite media conditions
for growth75 and further for simulating lethality versus
nonlethality responses to drug treatments. Network
reconstructions contain the requisite pathways for bio-
mass synthesis (i.e., growth); thus, in silico simulations
can be carried out in a systematic fashion in which each
gene is ‘deleted’ and the ability of the cell to grow can
then be tested. Similarly, in silico experiments can be
performed in which the response to a particular drug
is tested. This is achieved by inhibiting or eliminating
the activity of an enzymatic target of a drug within
the network and then interrogating the capabilities of
the in silico organism (e.g., testing the ability to gener-
ate biomass and carry flux through particular
pathways).14,68,76 In a study by Chavali et al.,77 the
authors elucidated potential combinatorial drug treat-
ment regimens that would inhibit growth. Similar algo-
rithms could be employed to study other parasites and
complement drug-screening efforts. Constraint-based
reconstructions and analyses have also provided
insight into growth conditions and drug sensitivity
for other important human parasites.78–80
In addition to the analysis of individual parasites,
models are being developed that include host cell path-
ways. Specifically, based on host and parasite genome
annotation, computational models can be recon-
structed for both the host and parasite. Then computa-
tional simulations can elucidate how the pathways of
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the two different organisms influence each other. For
example, the host–pathogen model analysis carried
out by Bordbar et al.81 was the first integrated,
simulation-capable host–pathogen metabolic network
reconstruction, in which two genome-scale network
reconstructions (a human host cell and a pathogen)
were functionally integrated. Host–pathogen interac-
tions in different infectious states were characterized
through analysis of transcriptomic data, which
revealed differences in flux states of the pathogen
(Mycobacterium tuberculosis) in latent versus pulmo-
nary versus meningeal tuberculosis. These differing
metabolic states are the result of the different tissues
as well as the different types of interactions between
the pathogen and host cell. Further, such differences
may suggest different treatment strategies, depending
on the site of the infection. This methodology is likely
to be critical in the analysis and interpretation of pro-
tozoan pathogen data. The development of host–
parasite models represents a new avenue of application
and much needed development. With the continued
expansion and completion of 1D annotation of human
parasites (Table 3), the concurrent and increasingly
active 2D annotation of these pathogens will lead to
an improved understanding of host–parasite interac-
tions, and in the process, yield meaningful predictions
and new hypotheses to test and validate in the wet lab.
Systems Biology to Help Mitigate
the Challenges Associated with
Host–Parasite Research
In addition to expanding the arsenal of tools available
to researchers, advancements in systems-biology-based
methods have helped address some of the most chal-
lenging obstacles associated with host–parasite
research. As summarized earlier, some of these chal-
lenges include the complex, stochastic nature of para-
sitic life cycles, the lack of effective methods for
culturing certain parasite developmental stages, and
the overwhelming percentage of uncharacterized para-
site genes. In this section, we will highlight some of the
most recent systems-biology-based studies that have
aimed to overcome these barriers.
Computational Methods to Deconvolute
Complex Parasite Mixtures
Although a number of methods have been developed to
synchronize or isolate specific developmental parasite
stages in vitro, mixed parasite populations are often
unavoidable in vivo, especially when analyzing patient
samples. This is problematic when examining system-
wide expression data, as different stages have been
shown to display distinct expression profiles. Clinical
surveillance of patients harboring transmissible
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parasite stages, such as thePlasmodium sexual gameto-
cyte stage, is critical for transmission reduction;82 how-
ever, this is difficult, as gametocytes comprise only a
very small fraction of all blood-stage Plasmodium
parasites during infection. To address this issue for
mixed populations of P. falciparum, researchers have
developed a statistical method6 that estimates the rela-
tive contributions of cell cycle and developmental stage
variation to the overall stochasticity of gene expression
data. The method was based on both transcriptomic
and microscopy analysis, and when applied to a pub-
lished dataset of in vivo patient samples, they found
that the previously reported variation in gene expres-
sionwas directly correlatedwith a changing proportion
of sexual-stage parasites. In addition, a recent study83
utilized computational analysis of transcriptomic data
in order to develop a novel qRT-PCR-based method
that can estimate the amount of both asexual and sex-
ual stages in patient samples. This strategy relied on the
selection and validation of a small panel of develop-
mentally associated transcriptional markers, a proce-
dure deeply rooted in systems biology.
Systems Analysis to Understand and Improve
In Vitro Parasite Culture
In vitro culture of parasites throughout their life cycle is
a valuable technique to more easily study host–parasite
biology. However, this is technically challenging for
many pathogen developmental stages. A notable exam-
ple is the stage conversion that occurs during
E. histolytica encystation, or the development from
pathogenic trophozoites into transmissible cysts, as this
process cannot be currently reproduced in vitro. In
Entamoeba invadens, a relatedEntamoeba species that
infects reptiles, stage conversion can be induced
in vitro. Several groups have recently mapped
E. invadens encystation on a system-wide scale in order
to better understand the biological processes control-
ling cyst formation, and in the process they provide
insight into the development of in vitro culturemethods
to induce E. histolytica encystation.10,44 These studies
led to the sequencing and assembly of the E. invadens
genome and global characterization of both transcrip-
tomic and metabolomic changes during encystation.
Interestingly, RNA-Seq analysis10 revealed that
phospholipase D, an enzyme involved in lipid second
messenger signaling, is required for efficient
E. invadens stage conversion in vitro. In addition,
MS-based metabolomics44 revealed that despite an
overall decrease in energy generation, there is an
increase in the levels of certain biogenic amines as well
as γ-aminobutyric acid (GABA) during encystation.
While it is still unclear how the biological processes
revealed by these data specifically contribute to
Entamoeba stage conversion, these studies provide
important insight into pathways that may be targeted
to induce E. histolytica in vitro. Additionally,
the metabolic enzymes controlling these processes
may be suitable targets for the development of
transmission-blocking drugs.
Genome-Wide Strategies to Assign Gene
Function to Hypothetical Genes
As previously emphasized, the majority of protozoan
parasite genomes are only half annotated, with around
50% of genes assigned a hypothetical or unknown
function (Figure 1). Because our understanding of
host–parasite interactions requires knowledge of both
host and parasite gene function, incomplete gene anno-
tation significantly stifles progress in this field. This
severely limits our basic understanding of parasite biol-
ogy and stunts our progress toward improved antipar-
asitic therapies, as drug discovery research benefits
from the functional annotation of parasite genes. There
has been an increased effort in recent years to apply
high-throughput phenotypic screening and chemical
genomics to identify novel parasite drug targets; how-
ever, often the genes targeted by promising compounds
are uncharacterized.3 Accordingly, significant effort
has been made to apply systems-biology-based meth-
ods in order to assign global gene function. Bioinfor-
matic analysis using comparative genomics is a
widely used strategy for predicting the function of
uncharacterized proteins.84 This method relies on the
evolutionary conservation of proteins with similar
function.While comparative genomics has been impor-
tant in the assignment of putative gene function for
many parasite genes,85,86 this analysis alone is not suf-
ficient for the characterization of whole parasite gen-
omes. There are notable examples where structurally
similar proteins have divergent functions, and likewise,
where proteins that have similar functions have diver-
gent sequences.87 Additionally, there are a number of
parasite proteins that do not have orthologs with
known function, and therefore traditional comparative
genomics would not be applicable. For example,
C. parvum is particularly divergent, with only 4% of
all the predicted open reading frames (ORFs) initially
assigned putative functions based on sequence homol-
ogy.88 Classical systems-based profiling of parasite
transcriptomes, proteomes, and metabolomes has
helped to build biological context for a number of these
uncharacterized proteins.54,89–91 However, experi-
mental evidence linking genotype to phenotype is still
required in order to adequately characterize protein
function.
In model systems, protein functional characteri-
zation has been largely achieved by phenotypic screens
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of genetically manipulated organisms. This -omics
strategy, called functional genomics, includes forward
genetic approaches, which identify the genetic basis for
phenotype, and reverse genetic approaches, which
identify the phenotypic consequence of genetic altera-
tion. Unfortunately, these functional genetic strategies
are challenging for many important human parasite
systems, as genome manipulation is technically diffi-
cult. Despite the challenges, a number of recent
genome-wide screening strategies have been success-
fully executed. Transposon mutagenesis using the pig-
gyBac transposable system has been particularly useful
as a forward genetic strategy in Plasmodium
species.92,93 Additionally, improvements in forward
genetic methods for chemical mutagenesis have facili-
tated functional genetics in organisms such as
T. gondii.94 Reverse genetic strategies, including both
gain-of-function and loss-of-function genetic screens,
have also come a long way in recent years. Genome-
wide overexpression screens have been a valuable
platform for characterizing protozoan parasite gene
function. These studies have identified genes
involved in phosphatidylinositol signaling as well as
phagocytosis for the human protozoan pathogen
E. histolytica.95,96 While overexpression screens are
useful because they can provide biological insight while
avoiding the problem of genetic redundancy, loss-of-
function screens can directly assess the phenotypic con-
sequence of repressing endogenous gene expression,
which in many cases is physiologically preferable.
Moreover, the ease of gene knockdown technologies
such as RNA interference (RNAi) has facilitated
high-throughput screening. While a number of proto-
zoan pathogens such as P. falciparum lack the cellular
machinery necessary for RNAi, others, like T. brucei,
have a functional RNAi pathway amenable to reverse
genetics.97 A number of recent genome-wide RNAi
screens have been carried out in T. brucei,98–100 and
these studies have led to the identification of many par-
asite genes controlling important biological processes
such as cell cycle progression, differentiation, and quo-
rum sensing. Alternative methods to regulate gene
expression in the genetically intractable Plasmodium
parasite species are highly sought after. Significant
progress has been made to this end, with the recent
development of reverse genetic technologies including
a tetracycline-repressible transactivator system,101 a
glmS ribozyme-based post-transcriptional knockdown
system,102 and an inducible TetR-aptamer system.103
Very recently, a genome-scale library consisting of
bar-coded genetic modification vectors was developed
as a reverse genetic screening resource for Plasmodium
berghei.104 Application of the genome-editing
CRISPR-Cas9 system to the study of malaria parasites
has also been successful,55,56,105 and as this technology
further develops, it will certainly improve our under-
standing of many hypothetical parasite proteins and
thus host–parasite biology as a whole.
SYSTEMS ANALYSIS HAS ADVANCED
OUR UNDERSTANDING
OF KEY ASPECTS OF
HOST–PARASITE BIOLOGY
An enormous amount of information has been pro-
duced from the generation of host–parasite systems-
biology datasets within the last decade. The proper
integration and interpretation of this ‘big data’ is criti-
cal in order to link experimental findings to useful bio-
logical knowledge. Because of the system-wide nature
of these datasets, a vast number of important and inter-
esting conclusions can usually be drawn from any given
systems-based study, although researchers often
choose to pursue only a limited number of noteworthy
findings. Interestingly, many systems-based publica-
tions have followed up on data that enhance our under-
standing of specific subfields of host–parasite biology.
Although this review will not attempt to encompass all
of these findings, we will review some of the leading
concepts arising from the analysis of recent genome-
wide datasets.
Regulation of Parasite Gene Expression
Understanding how parasites regulate gene expression
throughout their life cycle within a host is necessary in
order to fully appreciate the scope of host–parasite
interactions. For example, parasites can actively inter-
fere with host cell translation in order to hijack the cel-
lular resources required for their own gene expression
as well as suppress immune responses, as reviewed
elsewhere.57,58 The system-wide investigation of para-
site gene expression is also vital in understanding the
coordinated set of events underlying important host–
parasite interactions. The upregulation or downregula-
tion of parasite proteins during specific developmental
stages is dependent on the host cellular environment
and needs to be carefully controlled to ensure parasite
survival.
Genome-wide approaches have been particularly
important in the elucidation of the regulatory mechan-
isms governing parasite gene expression in recent years.
Although transcriptomics has emerged as a powerful
systems-based approach, it must be emphasized that
the quantitation of mRNA abundance is often an
imperfect indicator of global gene expression. Indeed,
for both prokaryotic and eukaryotic organisms, it
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has been demonstrated that mRNA levels correlate
with protein expression for only 50–70% of
genes,103 and for protozoan parasites, this number
may be even lower.106 Systems-based approaches have
been especially useful for characterizing the dynamic
control of parasite gene expression in recent years.
These studies have revealed that precise control of gene
expression is essential to drive the dramatic transfor-
mation that takes place as parasites cycle through
developmental stages, and that the apparent lack of
tight transcriptional regulation is remedied by exten-
sive post-transcriptional mechanisms.
In particular, translational delay, a process in
which protein expression is actively suspended for
expressed mRNA transcripts, is a common strategy
employed by many protozoan parasites. Translational
delay may be a particularly advantageous strategy for
parasites, as they must quickly adapt to new environ-
ments and undergo developmental switching in order
to survive; storing transcripts necessary for such adap-
tations allows for rapid changes in gene expression by
circumventing the time needed for transcription.
Genome-wide next-generation sequencing of both
steady-state mRNA as well as polysome-associated
transcripts during the asexual erythrocytic stage in
P. falciparum107 revealed widespread translational
repression across the genome during different stages
of the parasite life cycle. Surprisingly, more than
30%of parasite genes were found to be associatedwith
translational delay. Many of the repressed genes
appeared to be regulated by cell cycle stage and they
clustered into discrete biological processes. For exam-
ple, many genes associated with early-stage processes,
such as nutrient acquisition and erythrocyte remodel-
ing, were transcribed during the trophozoite or schiz-
ont stages, and were only actively translated
immediately following merozoite invasion. Another
genome-wide ribosomal profiling study of
P. falciparum blood stages108 provides additional sup-
port for a model whereby transcription of important
merozoite genes occurs during the previous stage and
is translationally upregulated during invasion. Transla-
tional delay has also been demonstrated during the sex-
ual gametocyte stage by temporary storage of specific
transcripts in P-bodies.109 Unlike the majority of other
eukaryotic organisms, Trypanosomes transcribe
almost all of their genes as large polycistronic clusters,
and thus lack transcriptional control for most genes.
Despite the absence of regulation at the level of tran-
scription, transcriptomic surveys110 have revealed
extensive variation in mRNA abundance across devel-
opmental stages, suggesting widespread post-
transcriptional control. Furthermore, the comparison
of proteomic expression using SILAC and MS to
transcriptomic datasets suggests that like Plasmodium,
mRNA abundance does not predict protein expression
for at least 30% of the T. brucei genome.111 The inte-
gration of data surveying global protein expression,
polysome-associated transcript abundance, and total
mRNA during these stages revealed extensive transla-
tional repression during the time when T. brucei pre-
pares for transmission.112
Parasite Utilization of Host Resources
While eukaryotic pathogens are often able to synthesize
a number of nutrients required for growth de novo, it is
often more advantageous to conserve the energy
required for biosynthesis and to instead hijack host-
derived resources. This is especially true for the acqui-
sition of host lipids, as protozoan parasites must
quickly assemble a large amount of new membrane
during replication within host cells. In Apicomplexan
parasites such as P. falciparum and T. gondii, fatty
acids are taken up from the host and converted into
triacylglycerides, where they are then stored in lipid
bodies.113 Recently, a system-wide survey of the Plas-
modium lipidome during liver-stage infection49
revealed a significant enrichment in fatty acids impor-
tant for membrane biogenesis, including phosphatidyl-
choline. Upon further investigation, it was found that
the parasite actively acquires host-derived phosphati-
dylcholine and that this process is essential for parasite
survival within hepatocytes.49 It has also been shown
that Leishmania parasites, while unable to synthesize
sphingomyelin themselves, are able to hydrolyze host
sphingomyelin in order to produce essential metabo-
lites.114 A comparative genomics study114 identified a
parasite enzyme, LaISCL, which is responsible for the
degradation of host-derived sphingomyelin, and
showed that this process is necessary for the prolifera-
tion of L. major parasites within their mammalian
hosts. More recently, the same group showed115 that
this enzyme is also responsible for sphingomyelin turn-
over in Leishmania amazonensis, although in this spe-
cies, the role of sphingomyelin degradation in
promoting virulence is quite different.
Many protozoan parasites live an intracellular
auxotrophic lifestyle, actively acquiring metabolites
from their nutrient-rich host in order to survive. For
instance, blood-stage Plasmodium parasites have lost
the ability to biosynthesize purine rings or amino acids,
and therefore scavenge host nucleotides to synthesize
DNA and catabolize host hemoglobin to generate
amino acids.47,59 Recent system-wide metabolomic
studies have been instrumental in profiling the complex
exchange of nutrients between parasites and their
hosts. A comprehensiveMS-based approach47 revealed
WIREs System Biology and Medicine Systems analysis of host–parasite interactions
Volume 7, November/December 2015 © 2015 The Authors. WIREs Systems Biology and Medicine published by Wiley Periodicals, Inc. 393
significant modulation of host metabolites during
blood-stage Plasmodium development. The authors
found that host arginine depletion was particularly
extensive, suggesting that this may contribute to
human malarial hypoargininemia and progression to
cerebral malaria. Another Apicomplexan parasite,
T. gondii, relies on host nutrients, such as carbon, in
order to proliferate within host cell vacuoles. In a com-
bined metabolomic and stable isotope labeling
approach, a recent study46 mapped the carbon metab-
olism pathway for T. gondii tachyzoites. This systems-
based analysis revealed that active catabolism of host
glucose and glutamine through an oxidative TCA cycle
is essential for parasite replication. Through these and
similar systems-biology-based surveys, it is becoming
clear that protozoan parasites have evolved complex
strategies to both usurp and exploit host resources.
Host Immune Response to
Parasitic Infection
In order to fully appreciate the complexity of host–
parasite interactions, the host immune response
must be considered. It is well established that while
most protozoan infections are self-limiting in immuno-
competent hosts, however, immunocompromised indi-
viduals can develop severe and often life-threatening
disease, suggesting that an effective immune response
is essential for regulating parasitic disease. Many
-omic-based strategies have contributed to our current
knowledge of how the innate and adaptive immune sys-
tems resist parasitic infection, and in many cases, exac-
erbate disease. In particular, recent transcriptomic
analyses of host–parasite systems have implicated the
host innate Toll-like receptor (TLR) and interferon
(IFN)-mediated proinflammatory pathways in the reg-
ulation of disease progression. Microarray analysis of
malaria patient samples116 demonstrated an upregula-
tion of TLR signaling genes that had sites for IFN-
inducible transcription factors. Upon subsequent anal-
ysis ofPlasmodium-infected rodents,116 it was revealed
that TLR9 and MyD88 are critical to initiate the cyto-
kine responses leading to acute malaria in vivo.
Another transcriptomic analysis of patient
responses117 further confirmed the enhancement of
IFN-stimulated genes (ISGs) upon infection with
malaria parasites, and interestingly, the same study
determined that TLR9-independent sensing of AT-rich
PlasmodiumDNA induces type I IFNs. In a dual RNA-
Seq approach,27 a recent report mapped host and path-
ogen transcriptomes during acute and chronic infection
with T. gondii. Analysis of the differentially expressed
transcripts revealed that many of the acute infection-
specific genes included ISGs such as guanylate-binding
proteins. Chronic infection-specific transcripts were
shown to comprise a unique set of immune genes,
including those important for antigen recognition
and presentation. Thus, these systems-level analyses
indicate that innate sensing of protozoan pathogens
is important for the induction of proinflammatory
responses aimed at controlling infection.
Parasitic disease is an evolutionary arms race; as
our immune systems attempt to fight off infection,
pathogens quickly respond by adapting to and subvert-
ing these attacks, often through elegant biological man-
euvers. Multiple -omic-based surveys have contributed
to our knowledge of how protozoan parasites actively
manipulate the host immune response in order to avoid
detection. Over a decade of systems-biology research
has shown that T. gondii downregulates the innate
immune response by multiple mechanisms. This
includes preventing host nuclear translocation of
proinflammatory transcription factors such as nuclear
factor kappa β (NF-κβ) and signal transducer and acti-
vator of transcription 1 (STAT1α), aswell as upregulat-
ing anti-inflammatory pathways such as those
involving the suppressor of cytokine signaling
(SOCS) proteins.118 A notable systems-based study119
utilized transcriptomics and pathway analysis to show
that Toxoplasma actively regulates host immune
responses, and through forward genetics, discovered
a parasite rhoptry kinase, ROP16, that is secreted into
the host cytoplasm to interfere with STAT signaling.
Additionally, Plasmodium parasites also secrete viru-
lence factors that specifically block host innate immune
signaling. During liver-stage development, Plasmo-
dium circumsporozoite protein (CSP) is exported and
localized to the host cell nucleus where it interferes with
the nuclear translocation of NF-κβ, and microarray
analysis confirms that at least 40 NF-κβ-responsive
genes are downregulatedwith CSP expression.120 Like-
wise, in the blood stages of the parasite, a high-
throughput protein interaction screen121 found that
Plasmodium merozoite surface protein 1 (MSP1) spe-
cifically binds to the human proinflammatory cytokine
S100P, and that this interaction blocked activation of
the host NF-κβ-mediated innate immune response.
Through these and other genome-wide investigations,
it is clear that while the host innate immune system is
essential in controlling parasitic infection, parasites
have evolved complex strategies to effectively dampen
these responses.
CONCLUSION
Parasitic disease research has significantly benefited
from systems analyses. Host–parasite systems are
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complex, with stochasticity across and within develop-
mental stages, are often technically challenging to
model experimentally, and are built upon incompletely
characterized genomic foundations. Despite the chal-
lenges, recent improvements in systems-level technolo-
gies have facilitated the generation of ‘big data’ to
model host–pathogen interactions. These analyses
have improved our current knowledge of the basic biol-
ogy driving parasitic infection, and have also yielded
novel tools to facilitate further research. Many -omic
surveys have been conducted, and global expression
data for important human protozoan parasites are
nowpublicly accessible through several pathogen data-
bases. Furthermore, algorithms for the integration and
interpretation of genomic, transcriptomic, and meta-
bolomic data have elucidated novel insights and
hypotheses into host–parasite interactions. In particu-
lar, systems biology approaches have shed light on
how parasites utilize post-transcriptional gene regula-
tion to quickly adapt to changing host environments,
hijack host-derived resources to establish intracellular
replication, and neutralize host immune responses to
escape host proinflammatory attacks.
Each new -omics survey comes with the promise to
‘solve biology’ and serve as a singular framework for bio-
logical understanding. Inevitably, this fails, not because
of overestimation of the utility of a particular measure-
ment, but rather, the failure to recognize the need for
multiple data types and for analysis to be carried out
in an integrated, cohesive manner. Significant insights
into host–parasite biology have been made with systems
biology, but technical challenges still limit the application
of systems approaches to parasite systems, leading to an
uneven distribution of genome-wide datasets across pro-
tozoan species and developmental stages. While a num-
ber of genomic and transcriptomic datasets have been
generated for these pathogens, functional annotation is
still absent for approximately half of all parasite genes,
and proteomic coverage is severely lacking. Moreover,
there is a complete absence of publicly accessiblemetabo-
lomic databases for protozoan pathogens.
Moving forward, the field of host–parasite biol-
ogy would greatly benefit from overcoming key defi-
ciencies in systems biology research. Necessary
advances include the optimization of parasite culturing
methods, the development of functional genetic
approaches (e.g., through the CRISPR-Cas9 system),
and computational models of host–parasite interac-
tions. These tools will enable the generation of more
genome-wide datasets for functional characterization
of parasite genes and provide tools for the analysis of
these data. Thus, there are many opportunities for
researchers to leverage systems biology to further a
field that is far from saturated. There is no doubt that
the increasing efficacy of systems-based approaches
will continue to improve our current understanding
of host–parasite interactions, and accordingly, the
treatment of parasitic disease.
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